Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001387131-23-003381
Filing Date
2023-03-13
Accepted
2023-03-13 18:27:25
Documents
1
Period of Report
2023-03-08

Document Format Files

Seq Description Document Type Size
1 zangeneh-form4a_030823.html 4/A  
1 zangeneh-form4a_030823.xml 4/A 6132
  Complete submission text file 0001387131-23-003381.txt   7747
Mailing Address 51 ADAM WAY ATHERTON CA 94027
Business Address
Zanganeh Mahkam (Reporting) CIK: 0001507650 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36866 | Film No.: 23728626

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations